-
2016-01-21 Merck KGaA, Darmstadt, Germany and BrandWatch Technologies Form Long-Term Partnership
-
2016-01-04 Updated Digital Version of Periodic Table of the Elements
-
2016-01-04 Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of...
-
2016-04-14 Merck KGaA, Darmstadt, Germany, Appoints Maya Martinez-Davis as Global Head of Oncology
-
2016-04-19 MilliporeSigma Earns Accreditation for Quality Control of Culture Media
-
2016-02-10 Amazing Lighting Experiences with Materials from Merck KGaA, Darmstadt, Germany
-
2016-04-25 Merck KGaA, Darmstadt, Germany Wins European Investor Relations Awards
-
2016-04-26 First Multi-use Disposable Sterile Connectors for Biopharma
-
2016-02-19 Treasury Team Wins European Prize for Sigma-Aldrich Acquisition Financing
-
2016-04-29 Annual General Meeting of Merck KGaA, Darmstadt, Germany, Approves Dividend Inc
-
2016-08-01 Merck KGaA, Darmstadt, Germany and Nanoco Sign Agreement
-
2016-03-02 Merck KGaA, Darmstadt, Germany, Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis
-
2016-08-02 Merck KGaA, Darmstadt, Germany Invests € 15 million in LC Window Technology
-
2016-12-01 Merck KGaA, Darmstadt, Germany Expands Distribution Agreementwith Roche
-
2016-04-14 Merck KGaA, Darmstadt, Germany, Responds to Legal Claims in the U.S.
-
2016-12-13 Merck KGaA, Darmstadt, Germany Presents Smart LCWindows at BAU 2017
-
2016-04-27 New MilliporeSigma Products Bring Ease of Use to Single-Use
-
2016-01-07 Collaboration on New Liquid Biopsy Technology
-
2016-07-01 Johann Heinrich Merck KGaA, Darmstadt, Germany, Award Goes To Kathrin Passig
-
2016-07-01 Merck KGaA, Darmstadt, Germany and University of Nairobi to Start Medical
-
2016-07-13 Merck KGaA, Darmstadt, Germany, Advances Water Purification Systems with New...
-
2016-06-29 Merck KGaA, Darmstadt, Germany, Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines
-
2016-07-27 Merck KGaA, Darmstadt, Germany Biopharma Innovation Cup Honors Young Scientists
-
2016-06-28 MilliporeSigma Expands Industry-Leading Emprove® Program
-
2016-06-28 MilliporeSigma to Develop Next-Generation Purification Processes with International Vaccine Institute
-
2016-06-07 Merck KGaA Announces Survey Results Exploring Biopharma Industry’s Evolving
-
2016-07-18 MilliporeSigma Relaunches Customer Collaboration Centers with New Concept and M Lab™ Name
-
2016-07-19 MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
-
2016-07-06 Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
-
2016-05-02 Merck KGaA, Darmstadt, Germany, Expands Production Know-how to Deliver Full...
-
2016-05-11 Merck KGaA, Darmstadt, Germany, Expands Popular Line of ...
-
2016-05-09 Merck KGaA, Darmstadt, Germany, Launches First Commercially Available
-
2016-05-10 Merck KGaA, Darmstadt, Germany, A High-Tech for the Automotive Industry
-
2016-05-09 Merck KGaA, Darmstadt, Germany, and Progyny Extend Collaboration for Eeva®
-
2016-05-04 Merck KGaA, Darmstadt, Germany, at SID: Materials for the Displays of
-
2016-05-04 Merck KGaA, Darmstadt, Germany, Builds on Leading Viral and Gene
-
2016-03-15 Photovoltaic Windows: Energy Efficient and Energy Generating
-
2016-03-29 Merck KGaA, Darmstadt, Germany, CRISPR Epigenetic
-
2016-03-07 Merck KGaA, Darmstadt, Germany, Launches Global Science Education
-
2016-03-08 Merck, KGaA, Darmstadt, Germany, Finishes Record Year 2015 Stronger
-
2016-03-07 Life Science Leader Merck KGaA, Darmstadt, Germany, Launches New Innovations
-
2016-11-16 Jens Frahm and Franz Pischinger Inducted into the Hall of Fame of German Research
-
2016-11-30 Merck KGaA, Darmstadt, Germany, Collaborates with Evotec for Faster Target Iden
-
2016-10-10 Merck KGaA, Darmstadt, Germany, Announces Recipients of Third Annual €1 Million ‘Grant for Oncology Innovation’ Award
-
2016-10-06 Merck KGaA, Darmstadt, Germany, Unveils New State-of-the-Art M Lab
-
2016-07-13 Merck KGaA, Darmstadt, Germany Awards Premio Letterario of Merck KGaA, Darmstadt, Germany in Rome
-
2016-08-03 MilliporeSigma Expands Portfolio of Certified Reference Materials
-
2016-08-01 MilliporeSigma to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound
-
2016-08-04 Merck KGaA, Darmstadt, Germany, Lifts Forecast Following Good Second Quarter
-
2016-08-23 Tagore Award India
-
2016-09-30 Merck KGaA, Darmstadt, Germany, Presents Its First Russian Literary Prize
-
2016-09-13 MilliporeSigma Lab Earns ISO Accreditation for Quality Control of Culture Media
-
2016-09-08 MilliporeSigma Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines
-
2016-09-26 MilliporeSigma Launches Viresolve® Pro Shield H for More Robust, Economical Parvovirus Removal
-
2016-09-19 MilliporeSigma’s New Steritest™ Symbio Pump Accessories Enable Faster, Sterility Testing in Any Setting
-
2016-09-07 Merck KGaA, Darmstadt, Germany, Opens New OLED Materials Production Plant in Darmstadt
-
2016-09-21 Merck KGaA, Darmstadt, Germany, Invests over € 50 million in Flagship Pharmaceutical Packaging Building in Darmstadt
-
2016-09-13 Merck KGaA, Darmstadt, Germany, Strengthens Display Materials R&D in China
-
2016-10-11 Merck KGaA, Darmstadt, Germany, Publishes First International Curiosity Study
-
2016-10-19 Merck KGaA, Darmstadt, Germany Donates 500 Millionth Praziquantel Tablet
-
2016-10-21 Kakehashi Literature Prize Presented in Japan
-
2016-10-05 MilliporeSigma’s Udit Batra Receives CPhI’s ‘CEO of the Year’ Award
-
2016-10-28 Merck KGaA, Darmstadt, Germany, Named as Top Employer by Science Magazine
-
2016-11-11 MilliporeSigma Wins R&D 100 Award for Top Invention
-
2016-11-04 Merck KGaA, Darmstadt, Germany, Invests € 250 Million in Production Value Chain in China
-
2016-11-22 Frosty-brilliant Silver Shine: The Merck KGaA, Darmstadt, Germany, Pigment Innovation Ronastar® Frozen Jewel
-
2016-10-18 Merck KGaA, Darmstadt, Germany, Showcases Innovative Effect Pigments and Processes at K2016
-
2016-11-15 Merck KGaA, Darmstadt, Germany, Raises Profit Forecast for 2016 Following Good Third Quarter
-
2016-12-05 MilliporeSigma to Provide Provantage® End-to-End Services to Acticor Biotech SAS
-
2016-12-08 Merck KGaA, Darmstadt, Germany, Appoints Thomas Möller as new Head of External Communications
-
2016-12-02 MilliporeSigma Launches Parteck® MXP Excipient for Increased Solubility
-
2016-10-13 MilliporeSigma Introduces First Certified Spiking Solution® of Heavy Labeled
-
2016-09-28 Merck KGaA, Darmstadt, Germany, to Present New Research Focused on Hard-to
-
2016-09-22 Merck KGaA, Darmstadt, Germany, and the Royal Health Awareness Society Partner
-
2016-09-08 Merck KGaA, Darmstadt, Germany, is Co-Creating the Cars of Tomorrow
-
2017-01-10 Merck KGaA, Darmstadt, Germany and CLEARink Displays Sign Development Agreement
-
2016-02-15 Merck KGaA, Darmstadt, Germany Presents New Material Advancements for Next Generation Lithography
-
2016-10-17 Merck KGaA, Darmstadt, Germany, Grants Rights to tutoProm™ Surface Coatings to durXtreme
-
2016-06-09 Accelerator Program of Merck KGaA, Darmstadt, Germany, Expands its Reach to Silicon Valley
-
2016-05-18 Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
-
2016-10-06 Merck KGaA, Darmstadt, Germany, Defines Blue-Glow Purple as the Effect Color of 2017
-
2016-04-29 Merck KGaA, Darmstadt, Germany, Annual General Meeting 2016: CEO Handover After Ten Successful Years
-
2016-11-07 Merck KGaA, Darmstadt, Germany and Idemitsu Signed Collaboration Agreement in the OLED Material Business
-
2016-04-14 Merck KGaA, Darmstadt, Germany, to Present Data On Comparative Effectiveness of Rebif® versus Oral Therapy at AAN Annual Meeting
-
2016-07-15 Dietmar Eidens Appointed Chief HR Officer (CHRO) of Merck KGaA, Darmstadt, Germany
-
2016-09-22 Merck KGaA, Darmstadt, Germany, Presents Displaying Futures Award for the First Time
-
2016-09-16 Merck KGaA, Darmstadt, Germany, Presents New Data Examining Durable Efficacy with Investigational Cladribine Tablets in Multiple Sclerosis
-
2016-10-31 European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
-
2016-04-05 Merck KGaA, Darmstadt, Germany, and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma
-
2017-01-10 MilliporeSigma Expands End-to-End Biodevelopment Centers in North America,
-
2016-11-14 Merck KGaA, Darmstadt, Germany Ranks Fourth in 2016 Access to Medicine Index
-
2016-10-13 Merck KGaA, Darmstadt, Germany, Sets its Sights on 2018 and Outlines Future Strategic Roadmap
-
2017-01-18 MilliporeSigma Launches First Commercial Service to Predict Multiple Sources of
-
2016-06-01 Merck KGaA, Darmstadt, Germany: Belén Garijo Receives Prestigious Career Award
-
2017-01-17 MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain
-
2016-09-15 "From Glitter to Glamour" – The Merck KGaA’s, Darmstadt, Germany, Pigment Innovation Ronastar® Royal Sparkle
-
2016-05-24 Merck KGaA, Darmstadt, Germany, Showcases Innovative Effect Pigments and Printing Technologies at Drupa 2016
-
2017-01-12 Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration
-
2016-05-30 For perfect white – Iriodin® 6111 Icy White Pristine KU26 from Merck KGaA, Darmstadt, Germany
-
2016-09-23 Merck KGaA, Darmstadt, Germany, Appoints Isabel De Paoli as Chief Strategy Officer
-
2016-07-18 Merck KGaA, Darmstadt, Germany, Receives European Medicines Agency Acceptance for Review of Marketing Authorization Application for Cladribine Tablets
-
2016-09-15 Merck KGaA, Darmstadt, Germany, Announces 2016 Recipients of €1 Million Grant for Multiple Sclerosis Innovation
-
2016-09-12 Merck KGaA, Darmstadt, Germany, Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif® at the 2016 ECTRIMS Congress
-
2017-01-19 Innovation Award for Organic Photovoltaics at the BAU 2017
-
2017-01-17 Merck KGaA, Darmstadt, Germany, Moves Executives Between Businesses
-
2016-01-19 Merck KGaA, Darmstadt, Germany, Appoints New Executive Board Members
-
2016-03-29 Merck KGaA, Darmstadt, Germany, Presents New Highlights at In-Cosmetics 2016: Make-up Trends, Innovative Protection and Personal Care Concepts
-
2016-07-08 Merck KGaA, Darmstadt, Germany, Launches New High-Temperature Pigment Series for the Ceramics Industry
-
2016-06-30 Merck KGaA, Darmstadt, Germany, Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance
-
2017-01-12 Merck KGaA, Darmstadt, Germany, Drives Business Opportunities in the U.S. to Fo
-
2016-11-02 Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at the 2016 ACR/ARHP Annual Meeting
-
2016-11-14 Merck KGaA, Darmstadt, Germany Confirm Potential of Atacicept
-
2016-06-06 ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma
-
2016-10-12 Plastics with 3D Effect: Merck KGaA, Darmstadt, Germany and PolyOne Agree to Collaborate
-
2016-09-12 Merck KGaA, Darmstadt, Germany Announces Recipients of the Grant for Growth Innovation 2016
-
2016-12-05 Ronastar® Red Allure: The elegant, matte pigment innovation from Merck KGaA, Darmstadt, Germany
-
2016-12-15 Xirallic® NXT Cougar Red: The mysterious colorintense pigment innovation from Merck KGaA, Darmstadt, Germany
-
2017-01-12 Merck KGaA, Darmstadt, Germany, Drives Business Opportunities in the U.S.
-
2017-01-11 Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development
-
2017-02-28 FDA Accepts the Biologics License Application for Avelumab for the Treatment...
-
2017-02-09 Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with...
-
2017-02-02 Merck KGaA, Darmstadt, Germany, appoints Anke Schenkel as Head of Group Control
-
2017-03-02 Allergopharma Opens new Biopharmaceutical Production in Reinbek
-
2017-03-30Merck KGaA, Darmstadt, Germany Advances R&D Strategy through Unique Development
-
2017-03-23 FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved
-
2017-03-22 “Bold & Vibrant”: Merck KGaA, Darmstadt, Germany, Presents Innovations at the E
-
2017-03-09 Merck KGaA, Darmstadt, Germany, Generates Record Sales and Continues to Grow Pr
-
2017-03-16 Merck KGaA, Darmstadt, Germany, Presents Special Effect Products and Concepts a
-
2017-04-24 Merck KGaA, Darmstadt, Germany Divests Biosimilars Business to Fresenius
-
2017-04-12 EU Horizon 2020 Project “HyperOLED” Successfully Launched
-
2016-05-19 Merck KGaA, Darmstadt, Germany, Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition
-
2016-06-08 Merck KGaA, Darmstadt, Germany, Expands its Corporate Ventures Fund
-
2016-11-14 MilliporeSigma Launches Next-Generation Technology for Advanced Live Cell Imaging
-
2017-01-04 MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testin
-
2017-03-06 MilliporeSigma Advances Lab Water Purification Technology with Milli-Q® IQ 7000
-
2017-04-06 New Full Spectrum (FS) Phosphors: Merck KGaA, Darmstadt, Germany, Presents Bran
-
2017-04-18 Merck KGaA, Darmstadt, Germany Furthers Commitment Towards Elimination of Schis
-
2016-01-27 Merck KGaA, Darmstadt, Germany, Announces New Biopharma Heads for North America
-
2016-02-16 Karl-Ludwig Kley Receives Weizmann Award in the Sciences and Humanities
-
2016-02-16 Merck KGaA, Darmstadt, Germany, and Weizmann Institute Sign New Framework Agree
-
2016-03-03 Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial
-
2016-05-24 Nigeria Receives Record Praziquantel Donation
-
2016-07-08 Your Merck KGaA, Darmstadt, Germany, news subscription: Chemicals is now Life S
-
2016-11-01 Merck KGaA, Darmstadt, Germany, Partners with American Cancer Society to Addres
-
2016-01-15 Merck KGaA, Darmstadt, Germany Announces Favorable UK Court Ruling on Name Use
-
2016-10-17 Merck KGaA, Darmstadt, Germany, Expands Biotech Production Capacity in Spain
-
2016-12-16 MilliporeSigma Wins Life Science Industry Award® for Most Memorable Advertising
-
2016-08-03 MilliporeSigma Expands Portfolio of Certified Reference Materials for Applied
-
2016-12-02 MilliporeSigma Introduces MILLIPLEX® High Sensitivity Panel for Faster, More
-
2016-07-12 MilliporeSigma Expands Excipients Portfolio, Adding Polymers for Sustained Rele
-
2016-06-08 Merck KGaA, Darmstadt, Germany, Expands its Corporate Ventures Fund
-
2016-06-28 MilliporeSigma Expands Industry-Leading Emprove® Program to Include Filtration
-
2016-03-21 MilliporeSigma Introduces IsoBag™ for Faster and Easier Transfer of Contact and
-
2016-11-14 Merck KGaA, Darmstadt, Germany’s Phase IIb ADDRESS II Results Confirm Potential
-
2016-09-14 Merck KGaA, Darmstadt, Germany, Joins DiViNe Consortium to Address Low Yields,
-
2016-09-13 MilliporeSigma Lab Earns ISO Accreditation for Quality Control of Culture Media
-
2016-11-29 FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
-
2016-10-17 Merck KGaA, Darmstadt, Germany, Expands Biotech Production Capacity in Spain
-
2017-06-04 Merck KGaA, Darmstadt, Germany Strengthens Immuno-Oncology Portfolio through Expansion of Fstar Collaboration including LAG-3/PD-L1 Bispecific Antibody
-
2017-04-28 We are a company driven by a passion for research and discovery
-
2017-04-28 Annual General Meeting of Merck KGaA, Darmstadt, Germany, Approves Dividend Increase
-
2017-05-09 MilliporeSigma Acquires Grzybowski Scientific Inventions to Expand Chemical Synthesis Offering
-
2017-05-17 Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017
-
2017-05-17 MilliporeSigma Develops Alternative CRISPR Genome Editing Method
-
2017-05-17 Shaping Cancer Care Today and Tomorrow: Merck, KGaA, Darmstadt, Germany, to Present New Data from Rapidly Evolving Pipeline at ASCO 2017
-
2017-05-09 FDA Grants Bavencio® approval for a common type of advanced bladder cancer
-
2017-05-16 MilliporeSigma’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune
-
2017-05-31 Anyone Can Become More Curious. Is That True?
-
2017-05-12 MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India
-
2017-05-16 Optimizing the Further Development of the Darmstadt Site
-
2017-05-15 MilliporeSigma Launches Industry’s First Off-the-Shelf Cell Culture Media for Perfusion Processes
-
2017-05-18 Liquid Crystals for New Optical Applications: Collaboration with the University of Leeds
-
2017-05-02 Merck KGaA, Darmstadt, Germany, and Schmid Rhyner AG cooperate on 3D technology for printing with depth effect
-
2017-05-08 Merck KGaA, Darmstadt, Germany, at SID: Future-oriented Materials for Displays and More
-
2017-01-23 Merck KGaA, Darmstadt, Germany, Announces Research Collaboration with Domain Th
-
2017-06-14 MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office
-
2017-06-15 Expand Distribution Agreement with Public Health England
-
2017-06-20 Our Company Creates New Immuno-Oncology Company iOnctura
-
2017-06-22 Pigment Innovation at the Laser World of Photonics 2017
-
2017-06-22 Sam Kean wins the 15th Premio Letterario Merck KGaA, Darmstadt, Germany
-
2017-06-23 Cladribine Tablets Receives Positive CHMP Opinion
-
2017-06-26 Displaying Futures Award Attracts High Interest
-
2017-06-26 MilliporeSigma adds Chemical Products to Reaxys’ Chemistry Database
-
2017-06-29 Our company and Industry Partners Create New Automotive Coating Effects
-
2017-07-06 Merck KGaA, Darmstadt, Germany, Biopharma Innovation Cup 2017
-
2017-07-05 Our Company Awards its 2017 Grant for Fertility Innovation (GFI)
-
2017-04-25 MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups
-
2017-05-01 MilliporeSigma’s Mobius® 2,000-liter Single-use Bioreactors to Expand Avid Bioservices’ Manufacturing Capabilities
-
2017-05-12 Constantin Birnstiel to Become Head of Group Communications at Merck KGaA, Darmstadt, Germany
-
2017-05-18 Merck KGaA, Darmstadt, Germany, Continues to Grow Profitably in the First Quarter
-
2017-07-06 Response on European Commission Statement of Objections
-
2017-07-12 Our company Refines Western European Life Science Production Site Network
-
2017-07-21 New Application Laboratory in Shanghai
-
2017-07-21 Avelumab
-
2017-08-03 Second-quarter results 2017
-
2017-08-03 European Patent Office to Grant Merck KGaA, Darmstadt, Germany’s Patent
-
2017-08-03 Executive Board Changes at Merck KGaA, Darmstadt, Germany
-
2017-08-03 Advance Vaccine Development and Manufacturing for Neglected Diseases
-
2015-01-01 News Archive 2015
-
2017-08-25 Mavenclad
-
2017-08-23 Merck KGaA, Darmstadt, Germany to Exhibit at the IAA for the First Time
-
2017-08-23 Merck KGaA, Darmstadt, Germany Sets Up PMatX Incubator in Israel
-
Seoul-Biennale-EN-2017-08-31
-
2017-08-31 ESMO 2017
-
2017-09-01-HEM-Award-2017
-
2017-09-01 Successful Closing of Biosimilars Transaction
-
2017-09-05 Merck KGaA, Darmstadt, Germany, Prepares Strategic Options for the CH
-
2017-09-07-IAA
-
2017-09-11 GOI Awards ESMO 2017
-
2017-09-11 PM-A new head names Heidi Fagerholm
-
2017-09-11 GOBDA-MOU-signin
-
2017-09-12 Merck KGaA, Darmstadt, Germany, Advances Immunology Pipeline with Evobrutinib
-
2017-09-14 IAA-Successful-Premiere
-
2017-09-18 Recipients of the Grant for Growth Innovation 2017
-
2017-09-21 Bavencio EC Approval
-
2017-09-21 ISAL-Automotive-Lighting
-
2017-09-25 Investors-Darling
-
2017-09-27 Bavencio-Japan-Approval
-
2017-09-28 Capital Markets Day 2017
-
2017-10-03 Merck KGaA, Darmstadt, Germany, invests € 35 Million in site of Bari
-
2017-10-05 Global Initiative
-
2017-10-11 New Life Science Center Burlington
-
2017-10-17 Merck KGaA, Darmstadt, Germany Presents New Clinical Data at ACR Annual Meeting
-
2017-10-19 Carlsbad
-
2017-10-20 Advanced Light Protection Award
-
2017-10-20 Science Top Employer
-
2017-10-24 Crispr Canada Patent
-
2017-10-26 ECTRIMS 2017
-
2017-10-25 LC-Windows-Frost-Sullivan-Award
-
2017-10-25 MS-in-Women-Report-Announcement
-
2017-11-01 Lupus Foundation of America collaboration with Merck KGaA, Darmstadt, Germany
-
2017-11-04 Late Breaking Clinical Data from Phase II Trial of Sprifermin
-
2017-11-09 Third quarter of 2017
-
2017-11-09 NICE Recommends Mavenclad
-
2017-11-09 Displaying-Futures-Tokyo
-
2017-11-17 Top Place to Work
-
2017-11-28 JAVELIN Gastric 300 Study
-
2017-11-30 Merck KGaA, Darmstadt, Germany, Opens Production Facility
-
2017-12-04 Cladribine Approved for Relapsing-Remitting MS in Canada
-
2017-12-05 Fertility Benchtop Incubator GeriTM
-
2017-12-07 Mavenclad Approval Australia
-
2017-12-12 Allan Gabor Takes Over Leadership in China
-
2017-12-13 New Partnership to Fight Schistosomiasis
-
2017-12-15 Corporate Affairs Wicklandt
-
2017-12-19 Singapore’s IP Office to Grant Milli’s Patent Application for CRISPR Technology
-
2017-12-21 Avelumab Breakthrough Designation RCC
-
2017-12-20 Collaboration with iCON™
-
2014-01-15 News Archive 2014
-
2013-01-15 Press Releases before 2014
-
2012-01-15 Press Releases before 2014
-
2011-01-15 Press Releases before 2014
-
2010-01-15 Press Releases before 2014
-
2009-01-15 Press Releases before 2014
-
2008-01-15 Press Releases before 2014
-
2018-01-16 ASCO GI Curtain Raiser
-
2018-01-26 New Chief Information Officer
-
2018-02-01 Researching New Highly Efficient OLEDs with Quantum Materials
-
2018-02-08 Merck KGaA, Darmstadt, Germany Plans 350 Good Deeds for its Anniversary Year
-
2018-02-13 MilliporeSigma Launches Viresolve® Barrier Capsule Filters
-
2018-02-15 Update on Phase III JAVELIN Lung
-
2018-02-16 Merck KGaA, Darmstadt, Germany, Named One of the Global Top Employers in 2018
-
ExploreBio
-
2018-02-20 Two Patents for CRISPR
-
2018-02-05 350th Anniversary
-
2018-02-05 Displaying-Futures-Award
-
2018-02-21 40 mn investment Asia
-
2018-02-22 Nine new signature partnerships
-
2018-02-28 Expanded Seeding Labs Part
-
2018-02-26 MAVENCLAD receives first approval in Latin America
-
2018-03-06-Evobrutinib in Relapsing Multiple Sclerosis
-
2018-03-08 Q4-FY Results of 2017
-
2018-03-13 Changes to Performance Materials Leadership Team
-
2018-03-19 Merck KGaA, Darmstadt, Germany Lights up Luminale 2018 in Frankfurt
-
2018-04-09 Mavenclad Receives First Approval in the Middle East & African Region
-
2018-03-27 Medisafe partnership
-
2018-03-27 Fast-Track Designation for Tepotinib
-
2018-04-12 MilliporeSigma Helps Accelerate Global Access to Affordable Vaccines
-
2018-04-13 Advance Multiple Sclerosis Treatment with MAVENCLAD and REBIF Data at AAN 2018
-
2018-04-17 new single use technologies to advance flexible manufacturing
-
2018-04-17 OARSI Curtain Raiser
-
2018-04-18 MilliporeSigma Wins INTERPHEX Exhibitor Award for Best Technological Innovation
-
2018-04-19 Consumer Health Divestiture
-
2018-04-19 Partnership-UCT-MMV
-
2018-05-03 Ceremony 350
-
2018-05-14 New Liquid Crystal Singles by Merck KGaA, Darmstadt, Germany on the SID 2018
-
2018-04-23 Patent for CRISPR technology in China
-
2018-04-27 MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer
-
2018-04-27 Annual General Meeting 2018
-
2018-04-27 Annual General Meeting 2018 Part 2
-
2018-05-02 Cladribine Tablets Data in MS Journal Show a Strong Treatment Effect
-
2018-05-02 Corporate Responsibility Report Documents Comprehensive Engagement
-
2018-05-02 Merck KGaA, Darmstadt, Germany to Develop Abituzumab
-
2018-05-15 Q1 - 2018
-
2018-05-16 MilliporeSigma to Use Genome Editing in Study of Gut Bacteria
-
2018-05-29 MilliporeSigma Announces Collaboration with Solvias
-
2018-05-16 Merck KGaA, Darmstadt, Germany, data at ASCO 2018 to showcase progress
-
2018-05-22 Merck KGaA, Darmstadt, Germany, Survey Reveals Most Thyroid Disorder Patients
-
2018-05-22 Merck KGaA, Darmstadt, Germany, Ignites Firework of Research Initiatives
-
2018-05-30 World MS Day 2018: Call for Greater Curiosity to Drive Understanding of the Disease and Future Innovation
-
2018-06-03 Merck KGaA, Darmstadt, Germany Presents Update on Tepotinib
-
2018-06-04 Merck KGaA, Darmstadt, Germany Presents Updated Clinical Results for M7824
-
2018-06-04 Update Javelin Merkel 200 Bavencio
-
2018-06-12 Thought Leadership in Ethical Gene Editing
-
2018-06-19 Agreement with HistoCyte Laboratories
-
2018-06-20 China Celebration 350
-
2018-06-20 OLED Lab China
-
2018-07-03 Performance Materials Strategy Update
-
2018-06-05 Bringing Biotechs Closer
-
2018-06-06 Final Registration REACH
-
2018-06-06 Merck KGaA, Darmstadt, Germany, Enhances Research in Ghana
-
2018-06-11 Update on Tepotinib Phase II Results
-
2018-06-12-Merck KGaA, Darmstadt, Germany Selects Three Winning Teams for Displaying Futur
-
2018-05-28 Digital Color Card App: Effect Pigments Go Digital
-
2018-06-14 Data on Investigational Cladribine Tablets and Rebif® in RMS
-
2018-06-18 Further Insight into the Efficacy of Investigational Cladribine Tablets
-
2018-07-17 Merck KGaA, Darmstadt, Germany, Announces Future Insight Prize
-
2018-07-26 Merck KGaA, Darmstadt, Germany receives recommendation for approval in 21 EU co
-
2018-07-26 MilliporeSigma and InnoCore Pharmaceuticals to Improve Patient Compliance with
-
2018-07-30 CladribineTablets FDA filing acceptance
-
2018-08-09 Q2 - 2018
-
2018-08-09 GL Changes
-
2018-08-15 Merck KGaA, Darmstadt, Germany, Awarded Australian CRISPR Nickase Patent
-
2018-09-04 MilliporeSigma Launches Next-Generation Process Technologies for Intensified Dr
-
2018-09-03 Ronastar® Black Allure: Merck KGaA, Darmstadt, Germany, introduces the next new
-
2018-09-10 New Application Labs in Philadelphia Enable Close Collaboration
-
2018-09-11 Positive Phase-III-Studie Bavencio plus Inlyta
-
2018-09-14 Merck KGaA, Darmstadt, Germany, Presents Interdisciplinary Cosmetics Research a
-
2018-09-21 MilliporeSigma Makes Major Investment in New Singapore Laboratory
-
2018-10-02 MilliporeSigma Announces $3,000 Grand Prize Winner of Alfred R. Bader Award for
-
04-10-2018 MilliporeSigma Opens M Lab™ Collaboration Center in São Paulo, Brazil
-
2018-10-08 New Efficacy and Safety Data on MS Portfolio to be Presented at ECTRIMS 2018
-
2018-10-11 Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosi
-
2018-10-09 ESMO Curtain Raiser
-
2018-10-10 Up to 10-Years of Follow-up Data Reaffirm Safety Profile of Investigational Cla
-
2018-10-12 MilliporeSigma Recognized with CPhI Awards for Innovative Products
-
2018-10-12 Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy
-
2018-10-16-Merck KGaA, Darmstadt, Germany, Aims to Return to Profitable Growth as of 2019
-
2018-10-17 Merck KGaA, Darmstadt, Germany Inaugurates State-of-the-art Pharma Packaging Ce
-
2018-10-18 MilliporeSigma Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Tec
-
2018-10-22 Merck KGaA, Darmstadt, Germany, Presents Updated Results for Bifunctional Immun
-
2018-10-23 Merck KGaA, Darmstadt, Germany unveils new product brand eyrise™
-
2018-10-30 Merck KGaA, Darmstadt, Germany, Presents First Curious Mind Researcher Award
-
2018-11-05 MilliporeSigma Launches BioContinuum™ Platform for Next-Generation Process Impr
-
2018-11-05 Embracing Carers™ expands support for caregivers worldwide
-
2018-11-06 Merck KGaA, Darmstadt, Germany Debuts at First China International Import Expo
-
2018-11-12 Merck KGaA, Darmstadt, Germany, Paves the Way for its Innovation Hub in Souther
-
2018-11-14 Q3 - 2018
-
Stefan Oschmann, Chairman of the Executive Board & CEO of Merck KGaA, Darmstadt, Germany
-
Udit Batra, Member of the Executive Board & CEO Life Science
-
Kai Beckmann, Member of the Executive Board & CEO Performance Materials
-
Belén Garijo, Member of the Executive Board & CEO Healthcare
-
Marcus Kuhnert, Member of the Executive Board & Chief Financial Officer
-
Biotechnology in a protein production laboratory in Corsier-sur-Vevey
-
Process development in Darmstadt for fast production scale-up
-
Merck KGaA, Darmstadt, Germany, defines progress in the field of chemical analysis
-
During film coating, nozzles spray a film onto the tablets
-
Gorian Nourdin next to a 4000 liter harvest tank in Corsier-sur-Vevey, Switzerland
-
Filling Erbitux® in Darmstadt for cancer patients in Europe
-
Innovative technology inside and outside: Chromolith® columns
-
Biotech: Checking the level in a centrifugation to separate cells
-
Waste Water Treatment Plant, EMD Serono in Vevey, Switzerland
-
Production of inorganic chemicals at Merck KGaA, Darmstadt, Germany
-
A high efficient solar module produced by using etching paste isishape SolarEtch
-
Chamomile man on the gravestone of the pharmacist Johann Frantz Merck
-
Part of the operating licence („Privileg“) for Friedrich Jacob Merck, 1668
-
Raw opium, the basic ingredient for the production of morphine
-
The start of childcare, Kindergarten E. Merck, Darmstadt, Germany, 1940
-
In the US and Canada only, we operate as EMD Serono in the Biopharma business.
-
In the US and Canada only, we operate as EMD Serono in the Biopharma business.
-
In the US and Canada only, we operate as EMD Serono in the Biopharma business.
-
In the US and Canada only, we operate as MilliporeSigma in the Life Science business.
-
In the US and Canada only, we operate as MilliporeSigma in the Life Science business.
-
In the US and Canada only, we operate as MilliporeSigma in the Life Science business.
-
In the US and Canada only, we operate as MilliporeSigma in the Life Science business.
-
In the US and Canada only, we operate as EMD Performance Materials
-
In the US and Canada only, we operate as EMD Performance Materials
-
In the US and Canada only, we operate as EMD Performance Materials
-
Protein crystals for 3D structural analysis of active ingredients and target proteins
-
Fertility research at the EMD Serono Research Institute
-
Laboratory work under cleanroom conditions
-
Automated weighing allows high experimental throughput in pharmaceutical research
-
Design study of headquarters in Darmstadt, Germany
-
Technical Centre Chilworth, Innovation Power house of the division Performance Materials
-
Aerial photo (from South West) of parts of our Headquarters
-
Headquarter building A1 - The building was constructed in 1903 and renovated in 1998.
-
The entrance to the administration building at the company´s headquarter in Darmstadt